IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells

IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells

Bibliographic Details
Main Authors:	E Dong, Xiao-zhu Yue, Lin Shui, Bin-rui Liu, Qi-qi Li, Yun Yang, Hui Luo, Wei Wang, Han-shuo Yang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-01-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-020-00357-7

Similar Items

PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response.
by: LanLan Liu, et al.
Published: (2020-01-01)

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
by: Jiawen Qian, et al.
Published: (2018-10-01)

CD137 ligand feedback upregulates PD‐L1 expression on lung cancer via T cell production of IFN‐γ
by: Helin Wang, et al.
Published: (2019-12-01)

PD-1+ IFN-γ+ subset of CD8+ T cell in circulation predicts response to anti–PD-1 therapy in NSCLC
by: Wenxiu Chen, et al.
Published: (2023-06-01)

CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition
by: Irene Andreu-Saumell, et al.
Published: (2024-04-01)

IFNγ-primed periodontal ligament cells regulate T-cell responses via IFNγ-inducible mediators and ICAM-1-mediated direct cell contact
by: Weerachai Singhatanadgit, et al.
Published: (2022-07-01)

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
by: Peter P Lee, et al.
Published: (2022-06-01)

IFN-γ Induces PD-L1 Expression in Primed Human Basophils
by: Srinivasa Reddy Bonam, et al.
Published: (2022-02-01)

BRAF inhibition curtails IFN‐gamma‐inducible PD‐L1 expression and upregulates the immunoregulatory protein galectin‐1 in melanoma cells
by: Patryk Górniak, et al.
Published: (2020-08-01)

Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8+ T cells in cerebral malaria
by: Yi Wang, et al.
Published: (2024-05-01)

PD-L1 is not constitutively expressed on Tasmanian devil facial tumor cells but is strongly upregulated in response to IFN-γ and can be expressed in the tumor microenvironment
by: Andrew Steven Flies, et al.
Published: (2016-12-01)

Upregulation of PD-L1 Expression by Prostaglandin E2 and the Enhancement of IFN-γ by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in Mycoplasma bovis Infection
by: Shinya Goto, et al.
Published: (2020-02-01)

PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma
by: Mamatha Garige, et al.
Published: (2022-05-01)

272 PD-L1 CAR engineered K-NK cells to target PD-L1+ or PD-L1- tumors
by: Pedro Romero, et al.
Published: (2023-11-01)

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
by: Guoping Ding, et al.
Published: (2019-11-01)

Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma
by: Yasunao Numata, et al.
Published: (2022-07-01)

IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM–1 release inhibits human rhinovirus infection
by: Spiteri Monica A, et al.
Published: (2008-06-01)

Effect of Rapamycin on Exosomes and PD-1/PD-L1 in Human Erythroleukemia HEL Cells
by: QI Lin, et al.
Published: (2022-10-01)

Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
by: Xiaojuan Shi, et al.
Published: (2019-11-01)

Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia
by: Shuxin Huang, et al.
Published: (2023-12-01)

PD-L1 mediated immune escape in nasopharyngeal carcinoma: Impact of LMP1 and IFN-γ on immune surveillance
by: Madhan Krishnan, et al.
Published: (2024-12-01)

Differentiation status determines the effects of IFNγ on the expression of PD-L1 and immunomodulatory genes in melanoma
by: Teitur Sævarsson, et al.
Published: (2024-12-01)

Upregulated PD-1 Expression Is Associated with the Development of Systemic Lupus Erythematosus, but Not the PD-1.1 Allele of the PDCD1 Gene
by: Qingqing Jiao, et al.
Published: (2014-01-01)

Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
by: Philipp Knopf, et al.
Published: (2023-12-01)

CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity
by: Yao Xiang, et al.
Published: (2024-04-01)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4<sup>+</sup> T Cells
by: Reem Saleh, et al.
Published: (2019-10-01)

Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade
by: Inna Serganova, et al.
Published: (2017-03-01)

The covalent modification of STAT1 cysteines by sulforaphane promotes antitumor immunity via blocking IFN-γ-induced PD-L1 expression
by: Qing Shi, et al.
Published: (2025-04-01)

Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
by: Yunlong Zhao, et al.
Published: (2018-07-01)

In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
by: Vishwanatha R. A. P. Reddy, et al.
Published: (2019-12-01)

PD-1, IL-10, IFN-γ and IL-12 form a network to regulate HIV-1-specific CD4 T Cell and antigen-presenting cell function
by: Porichis F, et al.
Published: (2012-09-01)

TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
by: Jinxin Li, et al.
Published: (2023-07-01)

IFN-γ blockade after genetic inhibition of PD-1 aggravates skeletal muscle damage and impairs skeletal muscle regeneration
by: Shuzhao Zhuang, et al.
Published: (2023-04-01)

Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
by: Lewis Zhichang Shi, et al.
Published: (2016-08-01)

Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity
by: Danielle Rosa Beserra, et al.
Published: (2022-01-01)

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
by: Zhengtao Jiang, et al.
Published: (2021-07-01)

Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer
by: Nong Y, et al.
Published: (2024-12-01)

Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
by: Qian Zhu, et al.
Published: (2022-04-01)

Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34+ cells and PD-L1 CAR-modified UCB-CD34+-derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells
by: Farhoodeh Ghaedrahmati, et al.
Published: (2024-08-01)

Lauric acid abolishes interferon-gamma (IFN-γ)-induction of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in human macrophages
by: Wei-Siong Lim, et al.
Published: (2015-09-01)